329 related articles for article (PubMed ID: 26527801)
21. Accumulation of cytolytic CD8+ T cells in B16-melanoma and proliferation of mature T cells in TIS21-knockout mice after T cell receptor stimulation.
Ryu MS; Woo MY; Kwon D; Hong AE; Song KY; Park S; Lim IK
Exp Cell Res; 2014 Oct; 327(2):209-21. PubMed ID: 25088256
[TBL] [Abstract][Full Text] [Related]
22. Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells.
Gao X; Wang X; Yang Q; Zhao X; Wen W; Li G; Lu J; Qin W; Qi Y; Xie F; Jiang J; Wu C; Zhang X; Chen X; Turnquist H; Zhu Y; Lu B
J Immunol; 2015 Jan; 194(1):438-45. PubMed ID: 25429071
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator-activated receptor alpha deficiency impairs regulatory T cell functions: Possible application in the inhibition of melanoma tumor growth in mice.
Hichami A; Yessoufou A; Ghiringhelli F; Salvadori F; Moutairou K; Zwetyenga N; Khan NA
Biochimie; 2016 Dec; 131():1-10. PubMed ID: 27613402
[TBL] [Abstract][Full Text] [Related]
24. miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokines.
Ji Y; Wrzesinski C; Yu Z; Hu J; Gautam S; Hawk NV; Telford WG; Palmer DC; Franco Z; Sukumar M; Roychoudhuri R; Clever D; Klebanoff CA; Surh CD; Waldmann TA; Restifo NP; Gattinoni L
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):476-81. PubMed ID: 25548153
[TBL] [Abstract][Full Text] [Related]
25. Caveolin-1 orchestrates TCR synaptic polarity, signal specificity, and function in CD8 T cells.
Tomassian T; Humphries LA; Liu SD; Silva O; Brooks DG; Miceli MC
J Immunol; 2011 Sep; 187(6):2993-3002. PubMed ID: 21849673
[TBL] [Abstract][Full Text] [Related]
26. CD8+ T regulatory cells use a novel genetic program that includes CD103 to suppress Th1 immunity in eye-derived tolerance.
Keino H; Masli S; Sasaki S; Streilein JW; Stein-Streilein J
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1533-42. PubMed ID: 16565389
[TBL] [Abstract][Full Text] [Related]
27. The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling.
Gracias DT; Stelekati E; Hope JL; Boesteanu AC; Doering TA; Norton J; Mueller YM; Fraietta JA; Wherry EJ; Turner M; Katsikis PD
Nat Immunol; 2013 Jun; 14(6):593-602. PubMed ID: 23603793
[TBL] [Abstract][Full Text] [Related]
28. LPA
Mathew D; Kremer KN; Strauch P; Tigyi G; Pelanda R; Torres RM
Front Immunol; 2019; 10():1159. PubMed ID: 31231367
[TBL] [Abstract][Full Text] [Related]
29. CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3.
Tang Q; Jiang J; Liu J
Inflammation; 2015 Dec; 38(6):2049-56. PubMed ID: 26047948
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of IL-2- versus IL-15-stimulated CD8 T cells in adoptive immunotherapy.
Mueller K; Schweier O; Pircher H
Eur J Immunol; 2008 Oct; 38(10):2874-85. PubMed ID: 18825743
[TBL] [Abstract][Full Text] [Related]
31. Enhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinases.
Riese MJ; Wang LC; Moon EK; Joshi RP; Ranganathan A; June CH; Koretzky GA; Albelda SM
Cancer Res; 2013 Jun; 73(12):3566-77. PubMed ID: 23576561
[TBL] [Abstract][Full Text] [Related]
32. Impaired signaling in alloantigen-specific CD8+ T cells tolerized in vivo: employing a model of Ld-specific TCR transgenic mice transplanted with allogenic hearts under the cover of a short-term rapamycin treatment.
Chen H; Luo H; Xu D; Loh DY; Daloze PM; Veillette A; Qi S; Wu J
J Immunol; 1996 Nov; 157(10):4297-308. PubMed ID: 8906803
[TBL] [Abstract][Full Text] [Related]
33. β-Adrenergic Signaling in Mice Housed at Standard Temperatures Suppresses an Effector Phenotype in CD8
Bucsek MJ; Qiao G; MacDonald CR; Giridharan T; Evans L; Niedzwecki B; Liu H; Kokolus KM; Eng JW; Messmer MN; Attwood K; Abrams SI; Hylander BL; Repasky EA
Cancer Res; 2017 Oct; 77(20):5639-5651. PubMed ID: 28819022
[TBL] [Abstract][Full Text] [Related]
34. Inhibiting Notch1 enhances immunotherapy efficacy in melanoma by preventing Notch1 dependent immune suppressive properties.
Qiu H; Zmina PM; Huang AY; Askew D; Bedogni B
Cancer Lett; 2018 Oct; 434():144-151. PubMed ID: 30036609
[TBL] [Abstract][Full Text] [Related]
35. Optimizing T-cell receptor avidity with somatic hypermutation.
Bassan D; Gozlan YM; Sharbi-Yunger A; Tzehoval E; Eisenbach L
Int J Cancer; 2019 Nov; 145(10):2816-2826. PubMed ID: 31381134
[TBL] [Abstract][Full Text] [Related]
36. Enhanced anti-tumor activity of interferon-alpha in SOCS1-deficient mice is mediated by CD4⁺ and CD8⁺ T cells.
Guenterberg KD; Lesinski GB; Mundy-Bosse BL; Karpa VI; Jaime-Ramirez AC; Wei L; Carson WE
Cancer Immunol Immunother; 2011 Sep; 60(9):1281-8. PubMed ID: 21604070
[TBL] [Abstract][Full Text] [Related]
37. Tolerant CD8 T cells induced by multiple injections of peptide antigen show impaired TCR signaling and altered proliferative responses in vitro and in vivo.
Dubois PM; Pihlgren M; Tomkowiak M; Van Mechelen M; Marvel J
J Immunol; 1998 Nov; 161(10):5260-7. PubMed ID: 9820498
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cells.
Rubinstein MP; Su EW; Suriano S; Cloud CA; Andrijauskaite K; Kesarwani P; Schwartz KM; Williams KM; Johnson CB; Li M; Scurti GM; Salem ML; Paulos CM; Garrett-Mayer E; Mehrotra S; Cole DJ
Cancer Immunol Immunother; 2015 May; 64(5):539-49. PubMed ID: 25676709
[TBL] [Abstract][Full Text] [Related]
39. Potentiating the Antitumor Activity of Cytotoxic T Cells
Kim HR; Park JS; Fatima Y; Kausar M; Park JH; Jun CD
Front Immunol; 2020; 11():591054. PubMed ID: 33597944
[TBL] [Abstract][Full Text] [Related]
40. SOCS-1 binding to tyrosine 441 of IFN-gamma receptor subunit 1 contributes to the attenuation of IFN-gamma signaling in vivo.
Starr R; Fuchsberger M; Lau LS; Uldrich AP; Goradia A; Willson TA; Verhagen AM; Alexander WS; Smyth MJ
J Immunol; 2009 Oct; 183(7):4537-44. PubMed ID: 19734231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
